{
    "2018-10-26": [
        [
            {
                "time": "2018-10-15",
                "original_text": "Abbott, AbbVie settle TriCor marketing case for $25 million",
                "features": {
                    "keywords": [
                        "Abbott",
                        "AbbVie",
                        "settle",
                        "TriCor",
                        "marketing",
                        "case",
                        "$25 million"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-10-16",
                "original_text": "Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "MRK",
                        "BMY",
                        "Q3",
                        "Earnings",
                        "Cancer",
                        "Data",
                        "ESMO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "iShares Core Dividend Growth ETF Experiences Big Inflow",
                "features": {
                    "keywords": [
                        "iShares",
                        "Core",
                        "Dividend",
                        "Growth",
                        "ETF",
                        "Big",
                        "Inflow"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-18",
                "original_text": "The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, ACHC, ADNT, HTHT and CWH",
                "features": {
                    "keywords": [
                        "Klein",
                        "Law",
                        "Firm",
                        "Reminds",
                        "Investors",
                        "Class",
                        "Actions",
                        "ABBV",
                        "ACHC",
                        "ADNT",
                        "HTHT",
                        "CWH"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-10-19",
                "original_text": "AbbVie (ABBV) Q3 Earnings Preview: What's Shaping Up?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "ABBV",
                        "Q3",
                        "Earnings",
                        "Preview"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-20",
                "original_text": "SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline – November 20, 2018",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "ALERT",
                        "Bronstein",
                        "Gewirtz",
                        "Grossman",
                        "LLC",
                        "Notifies",
                        "Investors",
                        "Class",
                        "Action",
                        "AbbVie",
                        "Inc.",
                        "ABBV",
                        "Lead",
                        "Plaintiff",
                        "Deadline"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-10-21",
                "original_text": "A Performance Overview of JNJ’s Imbruvica, Velcade, and Zytiga",
                "features": {
                    "keywords": [
                        "Performance",
                        "Overview",
                        "JNJ",
                        "Imbruvica",
                        "Velcade",
                        "Zytiga"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}